The clinical efficacy and safety of anlotinib combined with irinotecan as the second-line therapy in patients with small cell lung cancer

LYU Yi-hua, ZHAO Zi-long, HUANG Ge-hong, BA Ya-er, DU Wei, GAO Hui, ZHANG Mei-yun

Tianjin Medical Journal . 2021, (4): 436 -440 . DOI: 10.11958/20202963